A detailed history of Omers Administration Corp transactions in Incyte Corp stock. As of the latest transaction made, Omers Administration Corp holds 38,742 shares of INCY stock, worth $2.79 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
38,742
Previous 41,542 6.74%
Holding current value
$2.79 Million
Previous $2.52 Million 1.67%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $160,524 - $192,108
-2,800 Reduced 6.74%
38,742 $2.56 Million
Q2 2024

Aug 13, 2024

BUY
$51.18 - $63.75 $2.13 Million - $2.65 Million
41,542 New
41,542 $2.52 Million
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $4.26 Million - $5.8 Million
-67,500 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $1.23 Million - $1.62 Million
-16,900 Reduced 20.02%
67,500 $5.89 Million
Q3 2019

Nov 12, 2019

BUY
$72.82 - $86.52 $6.15 Million - $7.3 Million
84,400 New
84,400 $6.27 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.